drugset / Trial / NCT01962181

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

NCT01962181

Unknown 40 enrolled Hadassah Medical Organization
Non-randomizedParallel-groupSingle-blindDiagnostic

Summary

In this study we try to identify the signature of brain activity in the EEG of attention deficit disorder (ADHD) patients compared to healthy subjects under different doses of Ritalin (methylphenidate) treatment.

Timeline

Start
2013-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule